What is the appropriate evaluation and management for an adult male with acute onset gynecomastia?

Acute Onset Gynecomastia: Evaluation and Management

For adult males with acute onset gynecomastia and physical examination findings consistent with benign gynecomastia or pseudogynecomastia, imaging is not routinely indicated—clinical diagnosis alone is sufficient in most cases 1.

Initial Clinical Assessment

The cornerstone of evaluation is a focused clinical examination to distinguish true gynecomastia from other conditions and exclude malignancy 1, 2:

Key Physical Examination Findings

• Palpate for glandular tissue: Gynecomastia presents as soft, rubbery, or firm mobile tissue directly under the nipple, distinguishing it from pseudogynecomastia (fatty tissue only) 1
• Pain assessment: Gynecomastia is more likely painful than cancer, especially when present <6 months 1
• Bilateral vs unilateral: Approximately 50% of cases are bilateral; unilateral presentations require higher suspicion for malignancy 1
• Red flags for cancer: Hard, fixed mass; skin/nipple retraction; nipple discharge; eccentric location away from nipple 1
• Testicular examination: Palpate for testicular masses (germ cell tumors can cause gynecomastia) 2

Essential History Elements

Identify reversible causes and underlying pathology 2, 3:

• Medications/substances: Anabolic steroids (30% of cases in recent studies), spironolactone, finasteride, antiandrogens, marijuana, alcohol 1, 4
• Chronic diseases: Liver disease (11% of cases), chronic kidney disease, hyperthyroidism 1, 4
• Onset and duration: Acute onset warrants investigation; physiologic pubertal gynecomastia typically resolves within 24 months 2
• Sexual function: Symptoms of hypogonadism or hyperestrogenism 2

Diagnostic Workup

Laboratory Testing

Order the following panel when clinical examination confirms gynecomastia 2, 5:

• Total testosterone, estradiol, SHBG, LH, FSH
• Prolactin, TSH
• hCG, alpha-fetoprotein (to exclude testicular tumors)
• Liver and renal function tests

Key finding: 47.5% of cases show altered sex hormone levels related to excess body weight; elevated estradiol is characteristic of hepatogenic forms 4.

Imaging

Testicular ultrasound is recommended because palpation has low sensitivity for detecting testicular tumors 2.

Breast imaging (mammography or ultrasound) is NOT routinely indicated when clinical examination is consistent with benign gynecomastia 1. The ACR Appropriateness Criteria explicitly state imaging is "usually not appropriate" in this scenario 1.

Exception: Order breast imaging only if:

• Clinical examination is indeterminate or equivocal 1
• Suspicious features present (hard mass, skin changes, nipple discharge, eccentric location) 1
• Age ≥25 years with indeterminate findings (mammography preferred) 1
• Age <25 years with indeterminate findings (ultrasound preferred initially) 1

Important caveat: Ultrasound can lead to unnecessary benign biopsies, as gynecomastia may appear mass-like with vascularity on Doppler 1. If ultrasound shows suspicious features, obtain mammography before proceeding to biopsy 1.

Management Algorithm

1. Identify and Address Underlying Causes

• Discontinue offending medications/substances (anabolic steroids most common) 2, 4
• Treat underlying conditions (liver disease, hyperthyroidism, hypogonadism) 2
• Watchful waiting after addressing reversible causes 2

2. Observation vs Intervention

Observation is recommended for 2:

• Physiologic gynecomastia (pubertal, elderly)
• Recent onset (<6 months) after treating underlying cause
• Asymptomatic cases

Medical therapy is generally NOT recommended 2:

• SERMs (tamoxifen, raloxifene) and aromatase inhibitors are not justified in general practice (strong recommendation) 2
• Exception: Testosterone replacement ONLY for proven hypogonadism (not for gynecomastia treatment per se) 2

Surgery is indicated for 2:

• Long-standing gynecomastia (>12 months, likely fibrotic and irreversible)
• Significant psychological distress
• Failure of conservative management

3. When to Biopsy

Core needle biopsy is indicated if 2:

• Clinical picture suspicious for malignancy (hard, fixed mass; skin changes; bloody nipple discharge)
• Do NOT obtain imaging first—proceed directly to biopsy for clearly suspicious lesions 1

Critical Pitfalls to Avoid

1. Over-imaging benign cases: Routine mammography/ultrasound in clinically obvious gynecomastia leads to unnecessary procedures and false positives 1

2. Missing testicular cancer: Always examine testes and obtain testicular ultrasound, as germ cell tumors can present with gynecomastia 2

3. Prescribing unnecessary medications: Medical therapy with SERMs/AIs lacks evidence and is not recommended for routine gynecomastia 2

4. Ignoring medication history: Anabolic steroid use accounts for 30% of cases and is often underreported 4

5. Assuming bilateral = benign: While 50% of male breast cancers have coexisting gynecomastia, gynecomastia itself is not a risk factor for cancer 1

Age-Specific Considerations

• <25 years: Breast cancer extremely rare (1% <30 years); if examination indeterminate, ultrasound is preferred initial imaging 1
• ≥25 years: Breast cancer incidence increases with age (median 63 years); if examination indeterminate, mammography is preferred 1

The incidence of gynecomastia in adults is increasing progressively, rising from 5.4% to 14.4% between 2020-2024 in recent studies, with excess body weight and anabolic steroid use as major drivers 4.